SAN FRANCISCO, Feb. 20 /PRNewswire/ -- The Gladstone Center for Translational Research and the California Institute for Quantitative Biomedical Research (QB3) at the University of California, San Francisco (UCSF) are co-sponsoring the first annual Collaborative Drug Discovery (CDD) Community meeting. The QB3-sponsored CDD Community meeting will feature leading researchers discussing "open" modes of collaborative discovery with a special emphasis on infectious diseases of the developing world. This free event is on Monday, March 5th 2007 from 12:30-7:00 pm on the first floor Gladstone Institute Auditorium at the UCSF, Mission Bay Campus.
(Logo: http://www.newscom.com/cgi-bin/prnh/20070220/SFTU059LOGO ) Here is a list of confirmed speakers and panelists: * Christopher Lipinski, PhD Pfizer, retired. (Keynote presentation) * James McKerrow, MD, PhD Dept. of Pathology, QB3 - UCSF * Matthew Bogyo, PhD Dept. of Pathology, Stanford Medical School * David Roos, PhD Director Penn Genomics Institute, Univ. of Penn * Andrej Sali, PhD Dept of Biopharmaceutical Sciences, QB3 - UCSF * Anang Shelat, PhD St. Jude Children's Research Hospital
The future role of "Open" collaborative drug discovery for research on the infectious diseases of the developing world will be discussed, along with related timely topics. A provocative global research project to speed up malaria drug discovery and the fight against drug resistance by web-sharing unpublished data will be presented. A panel will discuss global health research collaborations from the perspectives of academia, industry, and foundations. In addition to the above mentioned panel and presentations, the meeting will include sixteen posters, software demonstrations, and training for using the CDD Community Database.
Who should attend? * Researchers who have collaborations requiring complex data sharing * CDD community members who want to set the direction of collaborative software * Scientists working in drug discovery * Students who want to learn more about the drug discovery industry * Anyone interested in new drugs for diseases of the developing world and global health Registration is free online at http://www.acteva.com/go/cdd .
To present a poster, also email the poster title and abstract to info@collaborativedrug.com.
For more information visit: http://www.collaborativedrug.com/pages/news .
About Collaborative Drug Discovery: Collaborative Drug Discovery (CDD) has developed a customizable, web-based database to archive, mine, and collaborate with pre-clinical drug discovery data. CDD enables scientists to
more effectively develop new drug candidates for commercial and humanitarian markets.
Photo: NewsCom: http://www.newscom.com/cgi-bin/prnh/20070220/SFTU059AP Archive: http://photoarchive.ap.orgPRN Photo Desk, photodesk@prnewswire.comCollaborative Drug Discovery, Inc.CONTACT: Barry A. Bunin, PhD, President of Collaborative Drug Discovery,Inc., +1-650-204-3084, or info@collaborativedrug.com
Web site: http://www.collaborativedrug.com/
